Molecular Partners continues to monitor the situation surrounding the COVID-19 pandemic and its potential impact on patients, our team, our partners and our business.
Presently, we can report no major disruptions. We are complying with all local and federal instructions as it relates to the safety of our employees, patients, and citizens. All employees who can are working remotely. Our laboratories remain operational and those employees who are in the office are practicing physical distancing and undertaking all appropriate safety measures.
We recognize that this is a fluid situation and we continue to evaluate what, if any, potential impacts may occur, and we will update accordingly. We look forward to resuming normal operations.
March 26, 2020